UCLA Hematology/Oncology-San Luis Obispo — San Luis Obispo, California

UCLA Hematology/Oncology-San Luis Obispo is a clinical research site located in San Luis Obispo, California, United States 93401.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology-San Luis Obispo has participated in 8 clinical trials with 6 currently active.

Therapeutic areas: Breast Cancer, HER2-positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC).

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in San Luis Obispo

Browse all research sites in California · View every site in San Luis Obispo

• California Polytechnic State University
• Healthy Kids Laboratory within the French Hospital Copeland Health Education Pavilion
• University of California Los Angeles - Jonsson Comprehensive Cancer Center,892 Aerovista Place, Suite 240
• Twin Cities Community Hospital
• University of California, Los Angeles (UCLA) - San Luis Obispo
• California Polytechnic University San Luis Obispo
• Pacific Central Coast Health Center-San Luis Obispo
• Coastal Integrative Cancer Care
• San Luis Dermatology & Laser Clinic
• Research Site
• San Luis Dermatology and Laser Clinic

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology-San Luis Obispo?

UCLA Hematology/Oncology-San Luis Obispo has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology-San Luis Obispo conducted?

UCLA Hematology/Oncology-San Luis Obispo has 8 clinical trials on record, with 6 currently active. Their work covers Breast Cancer, HER2-positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC).

Is UCLA Hematology/Oncology-San Luis Obispo accredited by Crixeo Clinical Trials?

UCLA Hematology/Oncology-San Luis Obispo has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Hematology/Oncology-San Luis Obispo?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.